Abstract: New functionally substituted 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters were synthesized from 2,4-dioxotetrahydro-1,3-thiazole and evaluated for their in vitro cytotoxicity against several human tumor cell lines and one normal lung fibroblast cell line.
INTRODUCTION
Dioxotetrahydrothiazole derivatives with a carbonyl group at positions 2 and 4 are an important group of heterocyclic compounds with diverse biological activities, i.e., they are also known as anti-neoplastics. 1, 2 Dioxotetrahydrothiazole derivatives have been extensively studied chemically as well as biologically, 3, 4 in an effort to generate new translation initiation inhibitors for cancer therapy. 5 2,4-Dioxotetrahydro-1,3-thiazoles inhibit growth of gastrointestinal, 6, 7 biliary and pancreatic adenocarcinoma cells. 8 This study was aimed at the preparation and biological evaluation of new derivatives of 2,4-dioxotetrahydro-1,3-thiazole containing the cholesterole substructure. The cited substructure is present in the known anti-neoplastic phenesterine 9 ( Fig. 1) .
RESULTS AND DISCUSSION
Several new 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters were prepared according to Scheme 1.The synthesis of 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters was performed in the following steps: condensation of 2,4-dioxotetrahydro-1,3-thiazole (1) with appropriate aldehydes, in the presence of morpholine as a catalyst, whereby the 5-arylidene-2,4-dioxotetrahydro-1,3-thiazoles (2a-e) were obtained. 10 The 5-arylidene derivatives (2a-e) were transformed into their potassium salts (3a-e) using potassium hydroxide in an ethanolic medium. The synthesized derivatives (3a-e) were isolated in pure form and used in the next step without further purification. 11 Treatment of 3a-e with cholesteryl chloroformate in refluxing dry acetone yielded the corresponding 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters (4a-e). All the newly synthesized compounds were characterized by IR, 1 H-NMR, MS spectroscopy and microanalyses.
The newly synthesized cholesterol esters 4a-e were preliminarily evaluated for their ability to inhibit the growth of human cervical carcinoma HeLa, breast adenocarcinoma MCF-7, colon adenocarcinoma HT29, melanoma Hs294T, prostate adenocarcinoma PC-3 and lung fibroblast cell line MRC-5.
Growth inhibition was evaluated by colorimetric sulphorhodamine B (SRB) assay. 12 Briefly, a single cell suspension was plated into 96-well microtitar plates (Costar, flat bottom) (5´10 3 cells per 180 ml of medium) and preincubated for 24 h at 37 o C, 5 % CO 2 . The tested substances were added to the growth medium, to all wells except for the control and microplates, which were incubated for 48 h. After 48 h, SRB assay was carried out: to all wells 50 % trichloroacetic acid (TCA) was added (50 ml). An hour later, the plates were washed with water and 75 ml of 0.4 % SRB was added. Half an hour later, the plates were washed with citric acid (1 %) and dried.
Finally, 200 ml 10 mmol/dm 3 TRIS (pH 10.5) base was added. The optical density was measured on a microplate reader (Multiscan MCC 340, Labsystems, at 540/690 nm). The growth inhibiton was expressed as a percent of cytotoxicity (CI %) calculated according to the formula: (1-A TEST /A CONTROL )´100. A TEST is the absorbance of the tested sample and A CONTROL is the absorbance of the control sample.
The results are presented in Table I . Compound 4a was inactive against HeLa, MCF-7, HT-29, Hs294T, MRC-5 cell lines but showed cytotoxic activity against PC-3.
Conversely, the analogue 4b was found to be the most active and inhibited the growth of HeLa, MCF-7, Hs294T and PC-3 cell lines but was inactive against HT-29 and normal lung fibroblast cells.
Compound 4c showed cytotoxic activity against cervical carcinoma HeLa and PC-3 cell lines and compound 4d was active against the MRC-5 cell line.
Compound 4e was completely inactive against MCF-7, HT-29, Hs294T, PC-3 and lung fibroblast MRC-5 cell lines, but showed activity against the HeLa cell line. In conclusion, five novel 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters were synthesized. Compound 4b was found to be the most active and inhibited the growth of 4 tumor cell lines but was inactive against normal lung fibroblast cells. Of the tumor cells, PC-3 cells were the most sensitive: 4 out of the 5 compounds strongly inhibited their growth.
EXPERIMENTAL
The solvent and all reagents used in this study were purchased from commercial suppliers and were used as received.
The infrared spectra (v in cm -1 ) were recorded on a Perkin Elmer FTIR 1725 X spectrophotometer. 
General synthetic procedure
5-Arylidene-2,4-dioxotetrahydro-1,3-thiazole potassium salt (1 mmol) was suspended in dry acetone (20 cm 3 ) and cholesteryl chloroformate (1 mmol) was added. The reaction mixture was heated under reflux for 2 h, and then filtered and evaporated to dryness. The obtained crystals of 5-arylidene-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl esters were recrystallized from an ethanol-water mixture. Polaze}i od 2,4-dioksotetrahidro-1,3-tiazola (1) kondenzacijom sa aldehidima u prisustvu morfolina kao katalizatora dobijeni su odgovaraju}i 5-ariliden-2,4-dioksotetrahidro-1,3-tiazoli (2a-e), koji su zatim transformisani u svoje kalijumove soli (3a-e). Kalijumove soli su reakcijom sa holesteril-hloroformijatom dale odgovaraju}e holesteril estre 5-ariliden-2,4-dioksotetrahidro-1,3-tiazol-3-karboksilnih kiselina (4a-e). Izvr{ena je procena biolo{ke aktivnosti sintetizovanih holesteril estara. (Primqeno 9. juna 2005) 
5-(5-Methyl-2-furfurylidene)-2,4-dioxotetrahydro-1,3-thiazole-3-carboxylic acid cholesteryl ester

